Medical Management of Intraductal Papillary Mucinous Neoplasm.
- Author:
Yong Tae KIM
1
Author Information
1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. yongtkim@snu.ac.kr
- Publication Type:Review ; English Abstract
- Keywords:
Intraductal papillary mucinous neoplasm;
Pancreas;
Cyst;
Treatment
- MeSH:
Adenocarcinoma, Mucinous/diagnosis/pathology/*therapy;
Carcinoma, Pancreatic Ductal/diagnosis/pathology/*therapy;
Carcinoma, Papillary/diagnosis/pathology/*therapy;
Diagnosis, Differential;
Ethanol/therapeutic use;
Humans;
Pancreatic Neoplasms/diagnosis/pathology/*therapy;
Risk Factors;
Tomography, X-Ray Computed
- From:The Korean Journal of Gastroenterology
2008;52(4):214-219
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Intraductal papillary mucinous neoplasm (IPMN) is frequently found recently and is a precancerous lesion. Main duct-type should be resected since it can easily progress to invasive IPMN, whereas branch duct-type (BD) usually remains silent without malignant transformation. BD-IPMN should be resected if it has mural nodule, thick wall or septum, or solid component which are the obvious risk factors for malignancy. If the cyst size of BD-IPMN is more than 3 cm in diameter without obvious risk factors, it can be followed-up regularly or can be treated either with surgical resection or endoscopic ultrasonography (EUS)-guided ethanol lavage. Small BD-IPMN less than 3 cm in size without risk factors can be followed up with sonography, CT scan or EUS annually.
